Annual EBITDA
$2.35 B
+$160.30 M+7.32%
December 1, 2024
Summary
- As of February 7, 2025, ISRG annual EBITDA is $2.35 billion, with the most recent change of +$160.30 million (+7.32%) on December 1, 2024.
- During the last 3 years, ISRG annual EBITDA has risen by +$217.70 million (+10.21%).
- ISRG annual EBITDA is now at all-time high.
Performance
ISRG EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$734.90 M
+$41.40 M+5.97%
December 1, 2024
Summary
- As of February 7, 2025, ISRG quarterly EBITDA is $734.90 million, with the most recent change of +$41.40 million (+5.97%) on December 1, 2024.
- Over the past year, ISRG quarterly EBITDA has increased by +$161.50 million (+28.17%).
- ISRG quarterly EBITDA is now at all-time high.
Performance
ISRG Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$2.69 B
+$161.50 M+6.40%
December 1, 2024
Summary
- As of February 7, 2025, ISRG TTM EBITDA is $2.69 billion, with the most recent change of +$161.50 million (+6.40%) on December 1, 2024.
- Over the past year, ISRG TTM EBITDA has increased by +$497.60 million (+22.74%).
- ISRG TTM EBITDA is now at all-time high.
Performance
ISRG TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ISRG EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +7.3% | +28.2% | +22.7% |
3 y3 years | +10.2% | +28.2% | +22.7% |
5 y5 years | +48.9% | +28.2% | +22.7% |
ISRG EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +20.9% | at high | +53.5% | at high | +39.1% |
5 y | 5-year | at high | +77.1% | at high | +408.9% | at high | +107.9% |
alltime | all time | at high | +7733.0% | at high | >+9999.0% | at high | >+9999.0% |
Intuitive Surgical EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | $2.35 B(+7.3%) | $734.90 M(+6.0%) | $2.69 B(+6.4%) |
Sep 2024 | - | $693.50 M(+2.1%) | $2.52 B(+5.0%) |
Jun 2024 | - | $679.10 M(+17.3%) | $2.41 B(+5.2%) |
Mar 2024 | - | $578.70 M(+0.9%) | $2.29 B(+4.5%) |
Dec 2023 | $2.19 B(+12.6%) | $573.40 M(-0.2%) | $2.19 B(+4.5%) |
Sep 2023 | - | $574.40 M(+2.5%) | $2.09 B(+4.3%) |
Jun 2023 | - | $560.50 M(+16.7%) | $2.01 B(+4.0%) |
Mar 2023 | - | $480.30 M(+0.3%) | $1.93 B(-0.6%) |
Dec 2022 | $1.94 B(-8.8%) | $478.70 M(-2.0%) | $1.94 B(-2.6%) |
Sep 2022 | - | $488.70 M(+1.1%) | $2.00 B(-1.8%) |
Jun 2022 | - | $483.60 M(-1.7%) | $2.03 B(-4.8%) |
Mar 2022 | - | $491.90 M(-7.4%) | $2.13 B(+0.2%) |
Dec 2021 | $2.13 B(+60.7%) | $531.30 M(+1.3%) | $2.13 B(+1.7%) |
Sep 2021 | - | $524.60 M(-10.6%) | $2.10 B(+9.7%) |
Jun 2021 | - | $586.80 M(+20.1%) | $1.91 B(+30.1%) |
Mar 2021 | - | $488.50 M(-1.4%) | $1.47 B(+10.7%) |
Dec 2020 | $1.33 B(-15.9%) | $495.60 M(+45.9%) | $1.33 B(+2.6%) |
Sep 2020 | - | $339.60 M(+135.2%) | $1.29 B(-5.6%) |
Jun 2020 | - | $144.40 M(-58.3%) | $1.37 B(-16.0%) |
Mar 2020 | - | $346.40 M(-24.9%) | $1.63 B(+3.3%) |
Dec 2019 | $1.58 B(+19.3%) | $461.40 M(+10.8%) | $1.58 B(+6.3%) |
Sep 2019 | - | $416.60 M(+2.7%) | $1.48 B(+5.1%) |
Jun 2019 | - | $405.70 M(+38.1%) | $1.41 B(+7.5%) |
Mar 2019 | - | $293.80 M(-20.2%) | $1.31 B(-0.7%) |
Dec 2018 | $1.32 B(+13.8%) | $368.30 M(+7.0%) | $1.32 B(+0.9%) |
Sep 2018 | - | $344.30 M(+12.3%) | $1.31 B(+3.1%) |
Jun 2018 | - | $306.60 M(+1.2%) | $1.27 B(+1.8%) |
Mar 2018 | - | $303.00 M(-15.0%) | $1.25 B(+7.5%) |
Dec 2017 | $1.16 B(+11.5%) | $356.60 M(+16.7%) | $1.16 B(+5.8%) |
Sep 2017 | - | $305.50 M(+7.6%) | $1.10 B(+2.5%) |
Jun 2017 | - | $283.80 M(+31.3%) | $1.07 B(+1.5%) |
Mar 2017 | - | $216.10 M(-26.2%) | $1.06 B(+1.3%) |
Dec 2016 | $1.04 B(+25.6%) | $293.00 M(+5.1%) | $1.04 B(+2.2%) |
Sep 2016 | - | $278.70 M(+4.1%) | $1.02 B(+6.8%) |
Jun 2016 | - | $267.70 M(+32.3%) | $954.10 M(+8.3%) |
Mar 2016 | - | $202.40 M(-25.2%) | $881.30 M(+6.2%) |
Dec 2015 | $829.50 M(+34.0%) | $270.50 M(+26.7%) | $829.50 M(+8.4%) |
Sep 2015 | - | $213.50 M(+9.5%) | $765.40 M(+4.7%) |
Jun 2015 | - | $194.90 M(+29.4%) | $730.90 M(+5.0%) |
Mar 2015 | - | $150.60 M(-27.0%) | $696.20 M(+12.4%) |
Dec 2014 | $619.20 M(-32.7%) | $206.40 M(+15.3%) | $619.20 M(-3.2%) |
Sep 2014 | - | $179.00 M(+11.7%) | $639.50 M(-1.8%) |
Jun 2014 | - | $160.20 M(+117.7%) | $651.30 M(-10.3%) |
Mar 2014 | - | $73.60 M(-67.5%) | $726.20 M(-21.0%) |
Dec 2013 | $919.80 M(-1.7%) | $226.70 M(+18.8%) | $919.80 M(-3.8%) |
Sep 2013 | - | $190.80 M(-18.8%) | $956.60 M(-3.6%) |
Jun 2013 | - | $235.10 M(-12.0%) | $992.40 M(-0.4%) |
Mar 2013 | - | $267.20 M(+1.4%) | $996.50 M(+6.5%) |
Dec 2012 | $935.90 M | $263.50 M(+16.3%) | $935.90 M(+5.8%) |
Sep 2012 | - | $226.60 M(-5.3%) | $884.40 M(+4.3%) |
Jun 2012 | - | $239.20 M(+15.8%) | $848.20 M(+7.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2012 | - | $206.60 M(-2.5%) | $788.30 M(+6.3%) |
Dec 2011 | $741.30 M(+24.5%) | $212.00 M(+11.3%) | $741.30 M(+6.8%) |
Sep 2011 | - | $190.40 M(+6.2%) | $693.80 M(+7.4%) |
Jun 2011 | - | $179.30 M(+12.3%) | $645.80 M(+4.8%) |
Mar 2011 | - | $159.60 M(-3.0%) | $616.00 M(+3.4%) |
Dec 2010 | $595.60 M(+44.6%) | $164.50 M(+15.5%) | $595.60 M(+4.8%) |
Sep 2010 | - | $142.40 M(-4.7%) | $568.20 M(+5.4%) |
Jun 2010 | - | $149.50 M(+7.4%) | $539.20 M(+8.2%) |
Mar 2010 | - | $139.20 M(+1.5%) | $498.20 M(+20.9%) |
Dec 2009 | $412.00 M(+22.6%) | $137.10 M(+20.9%) | $412.00 M(+12.8%) |
Sep 2009 | - | $113.40 M(+4.5%) | $365.14 M(+6.3%) |
Jun 2009 | - | $108.50 M(+104.7%) | $343.56 M(+7.6%) |
Mar 2009 | - | $53.00 M(-41.3%) | $319.42 M(-4.9%) |
Dec 2008 | $335.92 M(+52.9%) | $90.24 M(-1.7%) | $335.92 M(+4.1%) |
Sep 2008 | - | $91.82 M(+8.8%) | $322.78 M(+11.9%) |
Jun 2008 | - | $84.36 M(+21.4%) | $288.34 M(+14.4%) |
Mar 2008 | - | $69.50 M(-9.9%) | $252.08 M(+14.7%) |
Dec 2007 | $219.77 M(+54.1%) | $77.10 M(+34.4%) | $219.77 M(+6.5%) |
Sep 2007 | - | $57.37 M(+19.3%) | $206.41 M(+16.4%) |
Jun 2007 | - | $48.10 M(+29.3%) | $177.32 M(+13.7%) |
Mar 2007 | - | $37.19 M(-41.7%) | $155.91 M(+9.3%) |
Dec 2006 | $142.62 M(+88.9%) | $63.75 M(+125.4%) | $142.62 M(+36.9%) |
Sep 2006 | - | $28.28 M(+5.9%) | $104.18 M(+5.7%) |
Jun 2006 | - | $26.70 M(+11.7%) | $98.55 M(+11.0%) |
Mar 2006 | - | $23.90 M(-5.5%) | $88.82 M(+17.6%) |
Dec 2005 | $75.50 M(+166.8%) | $25.30 M(+11.7%) | $75.50 M(+20.0%) |
Sep 2005 | - | $22.65 M(+33.5%) | $62.90 M(+32.5%) |
Jun 2005 | - | $16.97 M(+60.4%) | $47.45 M(+29.2%) |
Mar 2005 | - | $10.58 M(-16.7%) | $36.74 M(+29.8%) |
Dec 2004 | $28.30 M(-2361.8%) | $12.70 M(+76.2%) | $28.30 M(+78.4%) |
Sep 2004 | - | $7.21 M(+15.3%) | $15.86 M(+121.1%) |
Jun 2004 | - | $6.25 M(+192.2%) | $7.17 M(+157.2%) |
Mar 2004 | - | $2.14 M(+704.1%) | $2.79 M(-322.9%) |
Dec 2003 | -$1.25 M(-92.0%) | $266.00 K(-118.0%) | -$1.25 M(-62.5%) |
Sep 2003 | - | -$1.48 M(-179.4%) | -$3.34 M(-55.6%) |
Jun 2003 | - | $1.86 M(-198.1%) | -$7.52 M(-39.8%) |
Mar 2003 | - | -$1.90 M(+4.5%) | -$12.49 M(-20.3%) |
Dec 2002 | -$15.67 M(-0.0%) | -$1.82 M(-67.9%) | -$15.67 M(-11.8%) |
Sep 2002 | - | -$5.66 M(+82.3%) | -$17.76 M(+5.8%) |
Jun 2002 | - | -$3.11 M(-38.9%) | -$16.78 M(-3.8%) |
Mar 2002 | - | -$5.08 M(+30.1%) | -$17.44 M(+14.4%) |
Dec 2001 | -$15.67 M(-10.6%) | -$3.91 M(-16.6%) | -$15.24 M(-6.1%) |
Sep 2001 | - | -$4.69 M(+24.4%) | -$16.24 M(+3.9%) |
Jun 2001 | - | -$3.77 M(+30.7%) | -$15.63 M(-0.9%) |
Mar 2001 | - | -$2.88 M(-41.2%) | -$15.77 M(-10.0%) |
Dec 2000 | -$17.52 M(+1.3%) | -$4.91 M(+20.4%) | -$17.52 M(+38.9%) |
Sep 2000 | - | -$4.07 M(+4.2%) | -$12.62 M(+47.7%) |
Jun 2000 | - | -$3.91 M(-15.7%) | -$8.55 M(+84.3%) |
Mar 2000 | - | -$4.64 M | -$4.64 M |
Dec 1999 | -$17.31 M(-43.8%) | - | - |
Dec 1998 | -$30.77 M | - | - |
FAQ
- What is Intuitive Surgical annual EBITDA?
- What is the all time high annual EBITDA for Intuitive Surgical?
- What is Intuitive Surgical annual EBITDA year-on-year change?
- What is Intuitive Surgical quarterly EBITDA?
- What is the all time high quarterly EBITDA for Intuitive Surgical?
- What is Intuitive Surgical quarterly EBITDA year-on-year change?
- What is Intuitive Surgical TTM EBITDA?
- What is the all time high TTM EBITDA for Intuitive Surgical?
- What is Intuitive Surgical TTM EBITDA year-on-year change?
What is Intuitive Surgical annual EBITDA?
The current annual EBITDA of ISRG is $2.35 B
What is the all time high annual EBITDA for Intuitive Surgical?
Intuitive Surgical all-time high annual EBITDA is $2.35 B
What is Intuitive Surgical annual EBITDA year-on-year change?
Over the past year, ISRG annual EBITDA has changed by +$160.30 M (+7.32%)
What is Intuitive Surgical quarterly EBITDA?
The current quarterly EBITDA of ISRG is $734.90 M
What is the all time high quarterly EBITDA for Intuitive Surgical?
Intuitive Surgical all-time high quarterly EBITDA is $734.90 M
What is Intuitive Surgical quarterly EBITDA year-on-year change?
Over the past year, ISRG quarterly EBITDA has changed by +$161.50 M (+28.17%)
What is Intuitive Surgical TTM EBITDA?
The current TTM EBITDA of ISRG is $2.69 B
What is the all time high TTM EBITDA for Intuitive Surgical?
Intuitive Surgical all-time high TTM EBITDA is $2.69 B
What is Intuitive Surgical TTM EBITDA year-on-year change?
Over the past year, ISRG TTM EBITDA has changed by +$497.60 M (+22.74%)